Pae W is a General Partner at SOSV where they invest at Pre-Seed, Seed, Series A, and Series C stages (including via convertible notes) across synthetic biology, neurotechnology, bioelectronic medicine, and novel materials/devices. They invest across North America, Europe, Asia, and MENA, including the United States, England, the European Union, China, and Hong Kong. Pae has invested in companies like MycoWorks, Prellis Biologics, Oxyle, Huue, and Chronus Health. Before SOSV, Pae was Chief Technical Officer at IndieBio; Scientific Director at Telefónica Innovation Alpha; Science Director at ONR Global (Office of Naval Research); and a Lead Biotechnologist/Scientific Consultant to DARPA at Berberian & Company, with prior research and academic roles at Duke University and CNRS. Pae graduated from Duke University.
Pae W, General Partner @ SOSV. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Pae W from sosv. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Pae
Map your path to Pae instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Pae
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.